Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Premature for clinical use; leaves open whether fibrinolysis targets will prove effective in human vascular disease.
Bodary et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: